Recent Finacing
Recent Raise
Addition Therapeutics is a San-Francisco-based genomic medicine company developing an all-RNA, non-viral, LNP-delivered PRINT platform to create therapeutics for chronic and rare diseases.
Focus Areas
Recent Investors
Total Raised
Funding round
See the team members at Addition Therapeutics.